Completed NA INTERVENTIONAL 2-arm NCT02448043

Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure

Sponsor: Allergan

Conditions Intraocular Pressure Nail Growth Cessation

Interventions Bimatoprost 0.01% Placebo: saline

Updated 9 times since 2017 Last updated: Nov 26, 2019 Started: Jun 4, 2015 Primary completion: May 6, 2016 Completion: May 6, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Intraocular Pressure and Nail Growth Cessation, this trial is completed. The trial is conducted by Allergan and has accumulated 9 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Jan 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 4 earlier versions

Nov 2018 — Jan 2020 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Nov 2018 [monthly]

Active Not Recruiting NA
Feb 2017 — Jun 2018 [monthly]

Active Not Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allergan
Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glenview, United States